Skip to content


Volume 6 Supplement 6

Beyond the Genome 2012

  • Poster presentation
  • Open Access

Transcriptomics analysis revealed an indirect effect of aqueous cigarette smoke extract in promoting the adhesion of monocytic cells to endothelial cells

  • 1,
  • 2,
  • 2,
  • 1,
  • 2,
  • 1,
  • 1 and
  • 2
BMC Proceedings20126 (Suppl 6) :P32

  • Published:


  • Cigarette Smoke
  • Human Umbilical Vein Endothelial Cell
  • Oxidative Stress Response
  • Adhesion Assay
  • Vascular Cell Adhesion


The adhesion of monocytic cells to the 'dysfunctional' endothelium constitutes a critical step in the initiation of atherosclerosis.

Cigarette smoke (CS) has been shown to contribute to the monocyte-endothelial adhesion process. However, the complex underlying molecular mechanisms remain to be unraveled.

Materials and methods

To investigate the impact of CS on the adhesion of monocytic cells to the endothelium, we developed a conditioned-medium experiment combined with an in vitro adhesion assay intended to mimic the situation found in the systemic compartment. Using a transcriptomics approach followed by confirmation experiments, we were able to identify a key mechanism by which aqueous CS extract in the form of smoke-bubbled phosphate buffered saline (sbPBS) promotes the adhesion of monocytic mono mac 6 (MM6) cells to human umbilical vein endothelial cells (HUVECs).


While soluble CS constituents elicit a strong oxidative stress response in both cell types, the induced expression of E-selectin, vascular cell adhesion molecule-1 (VCAM-1)and intercellular adhesion molecule-1 (ICAM-1) responsible for the binding of MM6 cells to HUVECs occurs through a pro-inflammatory paracrine effect. Our results show that this effect is largely driven by tumor necrosis factor α (TNF α) produced by MM6 cells exposed to sbPBS.


Our findings demonstrate that the adhesion of monocytic cells to endothelial cells is promoted through an indirect effect of sbPBS, mainly involving a key soluble factor TNF α and open new avenues for translational research in the comprehension of atherosclerosis development.

Authors’ Affiliations

Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland
Philip Morris International R&D, Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany


© Poussin et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.